Table 2.
Attributes | Affinity enrichment-based | Restriction enzyme-based | Bisulfite conversion |
---|---|---|---|
Assays | MeDIP-seq [81], MBD-seq [70] | HELP-seq [64], MRE-seq [65] | WGBS [46], RRBS [67] |
Resolution | Approximately 150 bp | Single base | Single base |
Regions covered | Approximately 23 million CpGs | Approximately 2 million CpGs | >28 million CpGs (WGBS) approximately 2 million CpGs (85% of CpG islands and 60% of promoters; RRBS) |
Advantages | Allows for rapid and specific assessment of the average methylation levels of large DNA regions, No mutation introduced, Cost-effective |
High sensitivity with lower costs, Simple approach, Cost-effective |
Evaluates methylation status of every CpG site |
Limitations | Limited by the quality and specificity of the antibody or protein, Bias into hyper-methylated regions, Unpredictable absolute methylation level, No information on separate CpG dinucleotides |
Restricted to restriction enzyme-digestion sites, Requires large amount, high purity, and integrity of DNA |
High cost, High DNA input, DNA damage after bisulfite conversion |
MeDIP-seq, methylated DNA immunoprecipitation and sequencing; MBD-seq, methylated-CpG-binding protein sequencing; HELP-seq, HpaII tiny fragments Enrichment by Ligation-mediated PCR; MRE-seq, methylation-sensitive restriction enzyme; WGBS, whole-genome bisulfite sequencing; RRBS, reduced-representation bisulfite sequencing; CpGs, cytosine phosphate guanine.